Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download

  Gastric Cancer

  Free Subscription

Articles published in Oncol Rep

Retrieve available abstracts of 181 articles:
HTML format

Single Articles

    September 2020
  1. SARALAMMA VVG, Vetrivel P, Lee HJ, Kim SM, et al
    Comparative proteomic analysis uncovers potential biomarkers involved in the anticancer effect of Scutellarein in human gastric cancer cells.
    Oncol Rep. 2020;44:939-958.
    PubMed     Abstract available

  2. LI C, Yuan L, Han S, Xuan M, et al
    Reduced Kiss1 expression is associated with clinical aggressive feature of gastric cancer patients and promotes migration and invasion in gastric cancer cells.
    Oncol Rep. 2020;44:1149-1157.
    PubMed     Abstract available

    August 2020
  3. SUI H, Zhu C, Li Z, Yang J, et al
    Propofol suppresses gastric cancer tumorigenesis by modulating the circular RNAPVT1/miR1955p/E26 oncogene homolog 1 axis.
    Oncol Rep. 2020 Aug 10. doi: 10.3892/or.2020.7725.
    PubMed     Abstract available

    July 2020
  4. REN M, Zhou X, Gu M, Jiao W, et al
    Resveratrol synergizes with cisplatin in antineoplastic effects against AGS gastric cancer cells by inducing endoplasmic reticulum stressmediated apoptosis and G2/M phase arrest.
    Oncol Rep. 2020 Jul 31. doi: 10.3892/or.2020.7708.
    PubMed     Abstract available

  5. SHAO Z, Gao D, Chen L, Ding W, et al
    Noncoding RNAs that regulate the Wnt/betacatenin signaling pathway in gastric cancer: Good cop, bad cop? (Review).
    Oncol Rep. 2020 Jul 28. doi: 10.3892/or.2020.7705.
    PubMed     Abstract available

  6. FUJITA N, Fujita K, Iwama H, Kobara H, et al
    Antihypertensive drug telmisartan suppresses the proliferation of gastric cancer cells in vitro and in vivo.
    Oncol Rep. 2020;44:339-348.
    PubMed     Abstract available

    March 2020
  7. XIANG A, Xue M, Ren F, Wang L, et al
    Highthroughput and continuous flow isolation of rare circulating tumor cells and clusters in gastric cancer from human whole blood samples using electromagnetic vibrationbased filtration.
    Oncol Rep. 2020 Mar 30. doi: 10.3892/or.2020.7567.
    PubMed     Abstract available

  8. MA J, Xia LL, Yao XQ, Zheng SM, et al
    BARX2 expression is downregulated by CpG island hypermethylation and is associated with suppressed cell proliferation and invasion of gastric cancer cells.
    Oncol Rep. 2020 Mar 22. doi: 10.3892/or.2020.7558.
    PubMed     Abstract available

  9. LIM SC, Kee KH, Lee MJ, Hong R, et al
    Extracellular acidityinduced expression of Kallikreinrelated peptidases 7 and 8 is involved in increased invasiveness of gastric cancer cells.
    Oncol Rep. 2020 Mar 3. doi: 10.3892/or.2020.7529.
    PubMed     Abstract available

    February 2020
  10. OHZAWA H, Saito A, Kumagai Y, Kimura Y, et al
    Reduced expression of exosomal miR29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.
    Oncol Rep. 2020 Feb 17. doi: 10.3892/or.2020.7505.
    PubMed     Abstract available

    December 2019
  11. ISHIKAWA A, Sakamoto N, Honma R, Taniyama D, et al
    Annexin A10 is involved in the induction of pancreatic duodenal homeobox1 in gastric cancer tissue, cells and organoids.
    Oncol Rep. 2019 Dec 2. doi: 10.3892/or.2019.7422.
    PubMed     Abstract available

    November 2019
  12. HIRAMATSU S, Tanaka H, Nishimura J, Yamakoshi Y, et al
    Gastric cancer cells alter the immunosuppressive function of neutrophils.
    Oncol Rep. 2019 Nov 20. doi: 10.3892/or.2019.7410.
    PubMed     Abstract available

  13. XU Y, Li X, Su X
    iTRAQbased proteomics analysis of the therapeutic effects of combined anticancer bioactive peptides and oxaliplatin on gastric cancer cells.
    Oncol Rep. 2019 Nov 11. doi: 10.3892/or.2019.7406.
    PubMed     Abstract available

  14. NISHIZAWA T, Nakano K, Fujii E, Komura D, et al
    In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model.
    Oncol Rep. 2019;42:1745-1754.
    PubMed     Abstract available

    October 2019
  15. LIN J, Shen J, Yue H, Cao Z, et al
    miRNA1835p.1 promotes the migration and invasion of gastric cancer AGS cells by targeting TPM1.
    Oncol Rep. 2019 Oct 4. doi: 10.3892/or.2019.7354.
    PubMed     Abstract available

    September 2019
  16. PENG X, Wang P, Li S, Jiang Y, et al
    Follistatinlike protein 1 knockdown elicits human gastric cancer cell apoptosis via a STAT6dependent pathway.
    Oncol Rep. 2019 Sep 24. doi: 10.3892/or.2019.7334.
    PubMed     Abstract available

    August 2019
  17. KIM SH, Choo GS, Yoo ES, Woo JS, et al
    Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells.
    Oncol Rep. 2019 Aug 28. doi: 10.3892/or.2019.7295.
    PubMed     Abstract available

  18. XIONG S, Hu M, Li C, Zhou X, et al
    Role of miR34 in gastric cancer: From bench to bedside (Review).
    Oncol Rep. 2019 Aug 16. doi: 10.3892/or.2019.7280.
    PubMed     Abstract available

    July 2019
  19. NIU G, Yang Y, Ren J, Song T, et al
    Overexpression of CPXM2 predicts an unfavorable prognosis and promotes the proliferation and migration of gastric cancer.
    Oncol Rep. 2019 Jul 30. doi: 10.3892/or.2019.7254.
    PubMed     Abstract available

    June 2019
  20. CHEN L, Shi Y, Zhu X, Guo W, et al
    IL10 secreted by cancerassociated macrophages regulates proliferation and invasion in gastric cancer cells via cMet/STAT3 signaling.
    Oncol Rep. 2019 Jun 19. doi: 10.3892/or.2019.7206.
    PubMed     Abstract available

  21. LIM SC, Parajuli KR, Han SI
    Keratin 6, induced by chronic cisplatin exposure, confers chemoresistance in human gastric carcinoma cells.
    Oncol Rep. 2019 Jun 18. doi: 10.3892/or.2019.7201.
    PubMed     Abstract available

  22. SHAH S, Pocard M, Mirshahi M
    Targeting the differentiation of gastric cancer cells (KATOIII) downregulates epithelialmesenchymal and cancer stem cell markers.
    Oncol Rep. 2019 Jun 12. doi: 10.3892/or.2019.7198.
    PubMed     Abstract available

  23. LIANG L, Zhao K, Zhu JH, Chen G, et al
    Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
    Oncol Rep. 2019 Jun 11. doi: 10.3892/or.2019.7195.
    PubMed     Abstract available

  24. GENG W, Tian D, Wang Q, Shan S, et al
    DNAPKcs inhibitor increases the sensitivity of gastric cancer cells to radiotherapy.
    Oncol Rep. 2019 Jun 6. doi: 10.3892/or.2019.7187.
    PubMed     Abstract available

  25. LIU H, Zhu Y, Zhu H, Cai R, et al
    Role of transforming growth factor beta1 in the inhibition of gastric cancer cell proliferation by melatonin in vitro and in vivo.
    Oncol Rep. 2019 Jun 6. doi: 10.3892/or.2019.7190.
    PubMed     Abstract available

  26. SUN B, Dang Y, Zhang F, Li K, et al
    Long noncoding RNA RP1163G9.1 is downregulated in gastric adenocarcinoma and is associated with a poor prognosis.
    Oncol Rep. 2019;41:3575-3585.
    PubMed     Abstract available

    May 2019
  27. TAO XC, Zhang XY, Sun SB, Wu DQ, et al
    miR92a contributes to cell proliferation, apoptosis and doxorubicin chemosensitivity in gastric carcinoma cells.
    Oncol Rep. 2019 May 23. doi: 10.3892/or.2019.7168.
    PubMed     Abstract available

  28. KIM J, Bae DH, Kim JH, Song KS, et al
    HOXC10 overexpression promotes cell proliferation and migration in gastric cancer.
    Oncol Rep. 2019 May 17. doi: 10.3892/or.2019.7164.
    PubMed     Abstract available

  29. ZHAO R, Zhao L, Xu X, Xu H, et al
    Analysis of microRNA expression profiles reveals a 5microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma.
    Oncol Rep. 2019;41:2775-2789.
    PubMed     Abstract available

    April 2019
  30. XI HQ, Cui JX, Shen WS, Wu XS, et al
    [Corrigendum] Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer.
    Oncol Rep. 2019 Apr 16. doi: 10.3892/or.2019.7120.
    PubMed     Abstract available

  31. KIM TW, Han SR, Kim JT, Yoo SM, et al
    Differential expression of tescalcin by modification of promoter methylation controls cell survival in gastric cancer cells.
    Oncol Rep. 2019 Apr 4. doi: 10.3892/or.2019.7099.
    PubMed     Abstract available

    March 2019
  32. LIN X, Xia Y, Hu D, Mao Q, et al
    Transcriptomewide piRNA profiling in human gastric cancer.
    Oncol Rep. 2019 Mar 18. doi: 10.3892/or.2019.7073.
    PubMed     Abstract available

  33. XIE R, Wang H, Jin H, Wen G, et al
    [Corrigendum] NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion.
    Oncol Rep. 2019 Mar 7. doi: 10.3892/or.2019.7055.
    PubMed     Abstract available

  34. LIN JX, Xie XS, Weng XF, Qiu SL, et al
    Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3beta/cyclin D1 signaling pathway.
    Oncol Rep. 2019 Mar 5. doi: 10.3892/or.2019.7042.
    PubMed     Abstract available

    February 2019
  35. MARUYAMA S, Furuya S, Shiraishi K, Shimizu H, et al
    Inhibition of apoptosis by miR1225p in alphafetoproteinproducing gastric cancer.
    Oncol Rep. 2019 Feb 20. doi: 10.3892/or.2019.7023.
    PubMed     Abstract available

  36. ZHANG Y, Yin W, Cao W, Chen P, et al
    CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
    Oncol Rep. 2019 Feb 12. doi: 10.3892/or.2019.7008.
    PubMed     Abstract available

  37. SHIMODA T, Wada R, Kure S, Ishino K, et al
    Expression of protein disulfide isomerase A3 and its clinicopathological association in gastric cancer.
    Oncol Rep. 2019 Feb 5. doi: 10.3892/or.2019.6999.
    PubMed     Abstract available

  38. ZHANG Z, Song N, Peng Y, Fan Z, et al
    Evironmental pollutant perfluorodecanoic acid upregulates cIAP2 to suppress gastric cell senescence.
    Oncol Rep. 2019;41:981-988.
    PubMed     Abstract available

  39. ZOU M, Hu X, Xu B, Tong T, et al
    Glutathione Stransferase isozyme alpha 1 is predominantly involved in the cisplatin resistance of common types of solid cancer.
    Oncol Rep. 2019;41:989-998.
    PubMed     Abstract available

    January 2019
  40. WANG Y, Qi Z, Zhou M, Yang W, et al
    Stanniocalcin1 promotes cell proliferation, chemoresistance and metastasis in hypoxic gastric cancer cells via Bcl2.
    Oncol Rep. 2019 Jan 23. doi: 10.3892/or.2019.6980.
    PubMed     Abstract available

  41. HU M, Zhu S, Xiong S, Xue X, et al
    MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
    Oncol Rep. 2019 Jan 10. doi: 10.3892/or.2019.6962.
    PubMed     Abstract available

    December 2018
  42. DONG YD, Yuan YL, Yu HB, Tian GJ, et al
    SHCBP1 is a novel target and exhibits tumorpromoting effects in gastric cancer.
    Oncol Rep. 2018 Dec 21. doi: 10.3892/or.2018.6952.
    PubMed     Abstract available

  43. KIM JL, Lee DH, Jeong S, Kim BR, et al
    Imatinibinduced apoptosis of gastric cancer cells is mediated by endoplasmic reticulum stress.
    Oncol Rep. 2018 Dec 19. doi: 10.3892/or.2018.6945.
    PubMed     Abstract available

  44. JIANG X, Zhang C, Li W, Jiang D, et al
    PEA15 contributes to the clinicopathology and AKTregulated cisplatin resistance in gastric cancer.
    Oncol Rep. 2018 Dec 18. doi: 10.3892/or.2018.6934.
    PubMed     Abstract available

  45. CHEN P, Zhao D, Wang W, Zhang Y, et al
    [Corrigendum] High expression of RELM-alpha correlates with poor prognosis and promotes angiogenesis in gastric cancer.
    Oncol Rep. 2018 Dec 17. doi: 10.3892/or.2018.6933.
    PubMed     Abstract available

  46. ZHANG W, Sun J, Chen J, Xu C, et al
    Downregulation of miR-95 in gastric cancer promotes EMT via regulation of Slug, thereby promoting migration and invasion.
    Oncol Rep. 2018 Dec 6. doi: 10.3892/or.2018.6911.
    PubMed     Abstract available

  47. NING J, Jiao Y, Xie X, Deng X, et al
    miR1385p modulates the expression of excision repair crosscomplementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.
    Oncol Rep. 2018 Dec 6. doi: 10.3892/or.2018.6907.
    PubMed     Abstract available

    November 2018
  48. WANG JB, Jin Y, Wu P, Liu Y, et al
    Tumor suppressor PLZF regulated by lncRNA ANRIL suppresses proliferation and epithelial mesenchymal transformation of gastric cancer cells.
    Oncol Rep. 2018 Nov 12. doi: 10.3892/or.2018.6866.
    PubMed     Abstract available

  49. LU J, Lin JX, Zhang PY, Sun YQ, et al
    CDK5 suppresses the metastasis of gastric cancer cells by interacting with and regulating PP2A.
    Oncol Rep. 2018 Nov 9. doi: 10.3892/or.2018.6860.
    PubMed     Abstract available

  50. YIN K, Shang M, Dang S, Wang L, et al
    [Corrigendum] Netrin1 induces the proliferation of gastric cancer cells via the ERK/MAPK signaling pathway and FAK activation.
    Oncol Rep. 2018 Nov 9. doi: 10.3892/or.2018.6863.
    PubMed     Abstract available

  51. XIAO WS, Li DF, Tang YP, Chen YZ, et al
    Inhibition of epithelialmesenchymal transition in gastric cancer cells by miR711mediated downregulation of CD44 expression.
    Oncol Rep. 2018;40:2844-2853.
    PubMed     Abstract available

  52. LIU N, Zhu M, Linhai Y, Song Y, et al
    Increasing HER2 alpha2,6 sialylation facilitates gastric cancer progression and resistance via the Akt and ERK pathways.
    Oncol Rep. 2018;40:2997-3005.
    PubMed     Abstract available

  53. LIU Z, Yu M, Fei B, Fang X, et al
    miR215p targets PDHA1 to regulate glycolysis and cancer progression in gastric cancer.
    Oncol Rep. 2018;40:2955-2963.
    PubMed     Abstract available

  54. ZHANG J, Ding W, Kuai X, Ji Y, et al
    Dermcidin as a novel binding protein of lncRNA STCAT3 and its effect on prognosis in gastric cancer.
    Oncol Rep. 2018;40:2854-2863.
    PubMed     Abstract available

    October 2018
  55. PENG JX, Liang SY, Li L
    sFRP1 exerts effects on gastric cancer cells through GSK3beta/Rac1mediated restraint of TGFbeta/Smad3 signaling.
    Oncol Rep. 2018 Oct 31. doi: 10.3892/or.2018.6838.
    PubMed     Abstract available

  56. XIONG X, Lu B, Tian Q, Zhang H, et al
    Inhibition of autophagy enhances cinobufagininduced apoptosis in gastric cancer.
    Oncol Rep. 2018 Oct 31. doi: 10.3892/or.2018.6837.
    PubMed     Abstract available

  57. YUAN J, Tan L, Yin Z, Tao K, et al
    GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on coexpression network analysis.
    Oncol Rep. 2018 Oct 15. doi: 10.3892/or.2018.6794.
    PubMed     Abstract available

  58. WEI H, Pu K, Liu XG, Li BX, et al
    The diagnostic value of circulating microRNAs as a biomarker for gastric cancer: A metaanalysis.
    Oncol Rep. 2018 Oct 11. doi: 10.3892/or.2018.6782.
    PubMed     Abstract available

  59. CHEN G, Yu C, Tang Z, Liu S, et al
    Metformin suppresses gastric cancer progression through calmodulinlike protein 3 secreted from tumorassociated fibroblasts.
    Oncol Rep. 2018 Oct 11. doi: 10.3892/or.2018.6783.
    PubMed     Abstract available

  60. PENG Y, Zhang X, Lin H, Deng S, et al
    Inhibition of miR194 suppresses the Wnt/betacatenin signalling pathway in gastric cancer.
    Oncol Rep. 2018 Oct 8. doi: 10.3892/or.2018.6773.
    PubMed     Abstract available

  61. ZHUANG X, Li X, Zhang J, Hu Y, et al
    Conditioned medium mimicking the tumor microenvironment augments chemotherapeutic resistance via ataxiatelangiectasia mutated and nuclear factorkappaB pathways in gastric cancer cells.
    Oncol Rep. 2018;40:2334-2342.
    PubMed     Abstract available

  62. WANG Y, Zhao E, Zhang Z, Zhao G, et al
    Association between Tim3 and Gal9 expression and gastric cancer prognosis.
    Oncol Rep. 2018;40:2115-2126.
    PubMed     Abstract available

  63. YU J, Qi J, Sun X, Wang W, et al
    MicroRNA181a promotes cell proliferation and inhibits apoptosis in gastric cancer by targeting RASSF1A.
    Oncol Rep. 2018;40:1959-1970.
    PubMed     Abstract available

  64. CHEN H, Wang J, Zhuang Y, Wu H, et al
    Identification of the potential molecular mechanism and driving mutations in the pathogenesis of familial intestinal gastric cancer by whole exome sequencing.
    Oncol Rep. 2018;40:2316-2324.
    PubMed     Abstract available

  65. YIN K, Shang M, Dang S, Wang L, et al
    Netrin1 induces the proliferation of gastric cancer cells via the ERK/MAPK signaling pathway and FAK activation.
    Oncol Rep. 2018;40:2325-2333.
    PubMed     Abstract available

  66. SHI Y, Chen Z, Gao J, Wu S, et al
    Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
    Oncol Rep. 2018;40:2014-2022.
    PubMed     Abstract available

    September 2018
  67. WANG F, Ruan L, Yang J, Zhao Q, et al
    TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelialtomesenchymal transition via activation of AKT signaling regulated by miR1955p.
    Oncol Rep. 2018 Sep 28. doi: 10.3892/or.2018.6750.
    PubMed     Abstract available

  68. YUMNAM S, Raha S, Kim SM, Venkatarame Gowda Saralamma V, et al
    Identification of a novel biomarker in tangeretininduced cell death in AGS human gastric cancer cells.
    Oncol Rep. 2018 Sep 24. doi: 10.3892/or.2018.6730.
    PubMed     Abstract available

  69. HE W, Zhang D, Li X, Wu J, et al
    TCGA datasetbased construction and integrated analysis of aberrantly expressed long noncoding RNA mediated competing endogenous RNA network in gastric cancer.
    Oncol Rep. 2018 Sep 21. doi: 10.3892/or.2018.6720.
    PubMed     Abstract available

  70. WANG J, Feng W, Dong Y, Mao X, et al
    MicroRNA495 regulates human gastric cancer cell apoptosis and migration through Akt and mTOR signaling.
    Oncol Rep. 2018 Sep 21. doi: 10.3892/or.2018.6722.
    PubMed     Abstract available

  71. WEI S, Sun T, Du J, Zhang B, et al
    Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro.
    Oncol Rep. 2018 Sep 21. doi: 10.3892/or.2018.6723.
    PubMed     Abstract available

  72. LIN Z, Liu W, Xiao C, Fan Y, et al
    TIPE2 inhibits GC via regulation of cell proliferation, apoptosis and inflammation.
    Oncol Rep. 2018;40:1307-1316.
    PubMed     Abstract available

    August 2018
  73. CORTELLINI A, Cannita K, Parisi A, Venditti O, et al
    Timedflat infusion of 5fluorouracil with docetaxel and oxaliplatin as firstline treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen.
    Oncol Rep. 2018;40:803-812.
    PubMed     Abstract available

    July 2018
  74. CHEN X, Li D, Wang N, Yang M, et al
    Bioinformatic analysis suggests that UGT2B15 activates the HippoYAP signaling pathway leading to the pathogenesis of gastric cancer.
    Oncol Rep. 2018 Jul 26. doi: 10.3892/or.2018.6604.
    PubMed     Abstract available

  75. QIN SC, Zhao Z, Sheng JX, Xu XH, et al
    Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion.
    Oncol Rep. 2018 Jul 24. doi: 10.3892/or.2018.6596.
    PubMed     Abstract available

  76. LV XY, Wang J, Huang F, Wang P, et al
    EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells.
    Oncol Rep. 2018 Jul 20. doi: 10.3892/or.2018.6586.
    PubMed     Abstract available

  77. WU C, Zhu X, Liu W, Ruan T, et al
    NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6574.
    PubMed     Abstract available

  78. WANG X, Hou Q, Zhou X
    LAMA4 expression is activated by zinc finger Eboxbinding homeobox 1 and independently predicts poor overall survival in gastric cancer.
    Oncol Rep. 2018 Jul 12. doi: 10.3892/or.2018.6564.
    PubMed     Abstract available

  79. WANG Y, Song Y, Che X, Zhang L, et al
    Caveolin1 enhances RANKLinduced gastric cancer cell migration.
    Oncol Rep. 2018 Jul 5. doi: 10.3892/or.2018.6550.
    PubMed     Abstract available

  80. PENG X, Zha L, Chen A, Wang Z, et al
    HOXA5 is a tumor suppressor gene that is decreased in gastric cancer.
    Oncol Rep. 2018 Jul 2. doi: 10.3892/or.2018.6537.
    PubMed     Abstract available

  81. ZHANG Z, Yu W, Chen S, Chen Y, et al
    Methylation of the claudin3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
    Oncol Rep. 2018;40:49-60.
    PubMed     Abstract available

    June 2018
  82. JI F, Sha H, Meng F, Zhu A, et al
    Tumorpenetrating peptide fused EGFR singledomain antibody enhances radiation responses following EGFR inhibition in gastric cancer.
    Oncol Rep. 2018 Jun 27. doi: 10.3892/or.2018.6532.
    PubMed     Abstract available

  83. NIE H, Mu J, Wang J, Li Y, et al
    miR1955p regulates multidrug resistance of gastric cancer cells via targeting ZNF139.
    Oncol Rep. 2018 Jun 25. doi: 10.3892/or.2018.6524.
    PubMed     Abstract available

  84. TENG F, Xu Z, Chen J, Zheng G, et al
    DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer.
    Oncol Rep. 2018 Jun 25. doi: 10.3892/or.2018.6520.
    PubMed     Abstract available

  85. DING X, Xi W, Ji J, Cai Q, et al
    HGF derived from cancerassociated fibroblasts promotes vascularization in gastric cancer via PI3K/AKT and ERK1/2 signaling.
    Oncol Rep. 2018 Jun 18. doi: 10.3892/or.2018.6500.
    PubMed     Abstract available

  86. ZHANG YH, Ma K, Liu JR, Wang HX, et al
    gamma-tocotrienol inhibits the invasion and migration of human gastric cancer cells through downregulation of cyclooxygenase-2 expression.
    Oncol Rep. 2018 Jun 14. doi: 10.3892/or.2018.6497.
    PubMed     Abstract available

  87. ZHANG B, Wu J, Cai Y, Luo M, et al
    AAED1 modulates proliferation and glycolysis in gastric cancer.
    Oncol Rep. 2018 Jun 7. doi: 10.3892/or.2018.6478.
    PubMed     Abstract available

    May 2018
  88. WU H, Liu X, Gong P, Song W, et al
    Elevated TFAP4 regulates lncRNA TRERNA1 to promote cell migration and invasion in gastric cancer.
    Oncol Rep. 2018 May 25. doi: 10.3892/or.2018.6466.
    PubMed     Abstract available

  89. YANG L, Yang G, Ding Y, Huang Y, et al
    Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6445.
    PubMed     Abstract available

  90. XIN J, Wang S, Zhang L, Xin B, et al
    Comparison of the synergistic anticancer activity of AlPcS4 photodynamic therapy in combination with different lowdose chemotherapeutic agents on gastric cancer cells.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6438.
    PubMed     Abstract available

  91. HUANG KH, Sung IC, Fang WL, Chi CW, et al
    Correlation between HGF/c-Met and Notch1 signaling pathways in human gastric cancer cells.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6447.
    PubMed     Abstract available

  92. KUMATA Y, Iinuma H, Suzuki Y, Tsukahara D, et al
    Exosomeencapsulated microRNA23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6418.
    PubMed     Abstract available

  93. XU G, Meng L, Yuan D, Li K, et al
    MEG3/miR21 axis affects cell mobility by suppressing epithelialmesenchymal transition in gastric cancer.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6424.
    PubMed     Abstract available

  94. WANG W, Liu J, Qi J, Zhang J, et al
    [Corrigendum] RLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer.
    Oncol Rep. 2018;39:2450.
    PubMed     Abstract available

    April 2018
  95. WANG Y, Zhang H, Ge S, Fan Q, et al
    Effects of miR1385p and miR2045p on the migration and proliferation of gastric cancer cells by targeting EGFR.
    Oncol Rep. 2018 Apr 23. doi: 10.3892/or.2018.6389.
    PubMed     Abstract available

  96. SHEN J, Li M, Min L
    HSPB8 promotes cancer cell growth by activating the ERKCREB pathway and is indicative of a poor prognosis in gastric cancer patients.
    Oncol Rep. 2018 Apr 18. doi: 10.3892/or.2018.6376.
    PubMed     Abstract available

  97. ZHANG YZ, Wang CF, Zhang LF
    Cucurbitacin D impedes gastric cancer cell survival via activation of the iNOS/NO and inhibition of the Akt signalling pathway.
    Oncol Rep. 2018 Apr 10. doi: 10.3892/or.2018.6361.
    PubMed     Abstract available

  98. LU L, Chen J, Li M, Tang L, et al
    betacarotene reverses tobacco smokeinduced gastric EMT via Notch pathway in vivo.
    Oncol Rep. 2018;39:1867-1873.
    PubMed     Abstract available

    March 2018
  99. FU ZH, Liu SQ, Qin MB, Huang JA, et al
    NIK and IKKbetabinding protein contributes to gastric cancer chemoresistance by promoting epithelialmesenchymal transition through the NFkappaB signaling pathway.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6348.
    PubMed     Abstract available

  100. SU B, Su J, Zeng Y, Ding E, et al
    Diallyl disulfide inhibits TGFbeta1induced upregulation of Rac1 and betacatenin in epithelialmesenchymal transition and tumor growth of gastric cancer.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6345.
    PubMed     Abstract available

  101. XU J, Gong L, Qian Z, Song G, et al
    ERBB4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6343.
    PubMed     Abstract available

  102. LUO Y, Chen X, Luo L, Zhang Q, et al
    [6]-Gingerol enhances the radiosensitivity of gastric cancer via G2/M phase arrest and apoptosis induction.
    Oncol Rep. 2018 Mar 5. doi: 10.3892/or.2018.6292.
    PubMed     Abstract available

  103. SUN JH, Li XL, Yin J, Li YH, et al
    A screening method for gastric cancer by oral microbiome detection.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6286.
    PubMed     Abstract available

    February 2018
  104. SONG J, Ma SJ, Luo JH, Zhang H, et al
    Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway.
    Oncol Rep. 2018 Feb 26. doi: 10.3892/or.2018.6282.
    PubMed     Abstract available

  105. WANG Q, Yang H, Zhuo Q, Xu Y, et al
    Knockdown of EPCR inhibits the proliferation and migration of human gastric cancer cells via the ERK1/2 pathway in a PAR-1-dependent manner.
    Oncol Rep. 2018 Feb 21. doi: 10.3892/or.2018.6276.
    PubMed     Abstract available

  106. CHEN Y, Liu J, Wang W, Xiang L, et al
    High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer.
    Oncol Rep. 2018 Feb 16. doi: 10.3892/or.2018.6273.
    PubMed     Abstract available

  107. GAO XY, Li L, Wang XH, Wen XZ, et al
    [Corrigendum] Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.
    Oncol Rep. 2018 Feb 14. doi: 10.3892/or.2018.6269.
    PubMed     Abstract available

  108. YAN H, Qiu C, Sun W, Gu M, et al
    Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy.
    Oncol Rep. 2018 Feb 7. doi: 10.3892/or.2018.6252.
    PubMed     Abstract available

  109. CHEN JW, Luo YJ, Yang ZF, Wen LQ, et al
    Knockdown of angiopoietin-like 4 inhibits the development of human gastric cancer.
    Oncol Rep. 2018 Feb 7. doi: 10.3892/or.2018.6253.
    PubMed     Abstract available

  110. ZHAO J, Geng L, Duan G, Xu W, et al
    REC8 inhibits EMT by downregulating EGR1 in gastric cancer cells.
    Oncol Rep. 2018 Feb 1. doi: 10.3892/or.2018.6244.
    PubMed     Abstract available

    January 2018
  111. XIONG J, Han S, Ding S, He J, et al
    Antibody-nanoparticle conjugate constructed with trastuzumab and nanoparticle albumin-bound paclitaxel for targeted therapy of human epidermal growth factor receptor 2-positive gastric cancer.
    Oncol Rep. 2018 Jan 9. doi: 10.3892/or.2018.6201.
    PubMed     Abstract available

  112. FAN H, Jiang M, Li B, He Y, et al
    MicroRNA-let-7a regulates cell autophagy by targeting Rictor in gastric cancer cell lines MGC-803 and SGC-7901.
    Oncol Rep. 2018 Jan 5. doi: 10.3892/or.2018.6194.
    PubMed     Abstract available

  113. TANG Q, Wang Y, Ma L, Ding M, et al
    Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR/FAK pathway.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6184.
    PubMed     Abstract available

  114. WANG TA, Xian SL, Guo XY, Zhang XD, et al
    Combined 18F-FDG PET/CT imaging and a gastric orthotopic xenograft model in nude mice are used to evaluate the efficacy of glycolysis-targeted therapy.
    Oncol Rep. 2018;39:271-279.
    PubMed     Abstract available

    December 2017
  115. WANG X, Liu B, Wen F, Song Y, et al
    MicroRNA-454 inhibits the malignant biological behaviours of gastric cancer cells by directly targeting mitogen-activated protein kinase 1.
    Oncol Rep. 2017 Dec 20. doi: 10.3892/or.2017.6171.
    PubMed     Abstract available

  116. HUANG Y, Zhu J, Li W, Zhang Z, et al
    Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
    Oncol Rep. 2017 Dec 19. doi: 10.3892/or.2017.6163.
    PubMed     Abstract available

  117. WU J, Zhang X, Wang Y, Sun Q, et al
    Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
    Oncol Rep. 2017 Dec 14. doi: 10.3892/or.2017.6155.
    PubMed     Abstract available

    November 2017
  118. KURATA A, Yamada M, Ohno SI, Inoue S, et al
    Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
    Oncol Rep. 2017 Nov 10. doi: 10.3892/or.2017.6093.
    PubMed     Abstract available

  119. LIAN G, Li L, Ye F, Wang D, et al
    The screening and analysis of protein signatures and signaling associated with chemoresistance based on Protein Pathway Array technology in gastric cancer.
    Oncol Rep. 2017 Nov 6. doi: 10.3892/or.2017.6078.
    PubMed     Abstract available

    October 2017
  120. LI Y, Wang K, Wei Y, Yao Q, et al
    lncRNA-MIAT regulates cell biological behaviors in gastric cancer through a mechanism involving the miR-29a-3p/HDAC4 axis.
    Oncol Rep. 2017 Oct 10. doi: 10.3892/or.2017.6020.
    PubMed     Abstract available

    September 2017
  121. FENG A, Yuan X, Li X
    MicroRNA-345 inhibits metastasis and epithelial-mesenchymal transition of gastric cancer by targeting FOXQ1.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6001.
    PubMed     Abstract available

  122. REN QG, Yang SL, Li PD, Xiong JR, et al
    Low heme oxygenase-1 expression promotes gastric cancer cell apoptosis, inhibits proliferation and invasion, and correlates with increased overall survival in gastric cancer patients.
    Oncol Rep. 2017 Sep 19. doi: 10.3892/or.2017.5967.
    PubMed     Abstract available

  123. CHENG Y, Jia B, Wang Y, Wan S, et al
    miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPARgamma in gastric cancer.
    Oncol Rep. 2017 Sep 7. doi: 10.3892/or.2017.5944.
    PubMed     Abstract available

  124. ZHANG W, Gu J, Chen J, Zhang P, et al
    Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition.
    Oncol Rep. 2017 Sep 6. doi: 10.3892/or.2017.5942.
    PubMed     Abstract available

    August 2017
  125. WANG P, Ma M, Zhang S
    EGF-induced urokinase plasminogen activator receptor promotes epithelial to mesenchymal transition in human gastric cancer cells.
    Oncol Rep. 2017 Aug 24. doi: 10.3892/or.2017.5920.
    PubMed     Abstract available

  126. XU D, Shao W, Jiang Y, Wang X, et al
    FTO expression is associated with the occurrence of gastric cancer and prognosis.
    Oncol Rep. 2017 Aug 14. doi: 10.3892/or.2017.5904.
    PubMed     Abstract available

  127. WANG X, Fu R, Hu Y, Du H, et al
    EGFR gene status predicts response and survival benefit in a preclinical gastric cancer trial treating patientderived xenografts with cetuximab.
    Oncol Rep. 2017 Aug 14. doi: 10.3892/or.2017.5907.
    PubMed     Abstract available

  128. GUO J, Yan Y, Yan Y, Guo Q, et al
    Tumor-associated macrophages induce the expression of FOXQ1 to promote epithelial-mesenchymal transition and metastasis in gastric cancer cells.
    Oncol Rep. 2017 Aug 3. doi: 10.3892/or.2017.5877.
    PubMed     Abstract available

    July 2017
  129. CHEN T, Huang Z, Tian Y, Wang H, et al
    Role of triosephosphate isomerase and downstream functional genes on gastric cancer.
    Oncol Rep. 2017 Jul 24. doi: 10.3892/or.2017.5846.
    PubMed     Abstract available

  130. JI R, Zhang X, Qian H, Gu H, et al
    miR-374 mediates the malignant transformation of gastric cancer-associated mesenchymal stem cells in an experimental rat model.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5831.
    PubMed     Abstract available

  131. TAO Y, Sun C, Zhang T, Song Y, et al
    SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells.
    Oncol Rep. 2017 Jul 17. doi: 10.3892/or.2017.5825.
    PubMed     Abstract available

  132. CHEN T, Wang K, Tong X
    In vivo and in vitro inhibition of human gastric cancer progress by upregulating Kank1 gene.
    Oncol Rep. 2017 Jul 17. doi: 10.3892/or.2017.5823.
    PubMed     Abstract available

  133. GONG YC, Ren GL, Liu B, Li F, et al
    miR206 inhibits cancer initiating cells by targeting EHF in gastric cancer.
    Oncol Rep. 2017 Jul 6. doi: 10.3892/or.2017.5794.
    PubMed     Abstract available

  134. YUAN X, Zhang T, Zheng X, Zhang Y, et al
    Overexpression of SET oncoprotein is associated with tumor progression and poor prognosis in human gastric cancer.
    Oncol Rep. 2017 Jul 4. doi: 10.3892/or.2017.5788.
    PubMed     Abstract available

    June 2017
  135. ZHOU J, Wu A, Yu X, Zhu J, et al
    SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway.
    Oncol Rep. 2017 Jun 27. doi: 10.3892/or.2017.5753.
    PubMed     Abstract available

  136. GE F, Wang C, Wang W, Liu W, et al
    MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Oncol Rep. 2017 Jun 27. doi: 10.3892/or.2017.5758.
    PubMed     Abstract available

  137. CHEN X, Yuan LQ, Li LJ, Lv Y, et al
    Suppression of gastric cancer by extract from the tuber of amorphophallus konjac via induction of apoptosis and autophagy.
    Oncol Rep. 2017 Jun 22. doi: 10.3892/or.2017.5747.
    PubMed     Abstract available

  138. PANG L, Li B, Zheng B, Niu L, et al
    miR-138 inhibits gastric cancer growth by suppressing SOX4.
    Oncol Rep. 2017 Jun 22. doi: 10.3892/or.2017.5745.
    PubMed     Abstract available

  139. TIAN W, Shen J, Chen W
    Suppression of midkine gene promotes the antitumoral effect of cisplatin on human gastric cancer cell line AGS in vitro and in vivo via the modulation of Notch signaling pathway.
    Oncol Rep. 2017 Jun 22. doi: 10.3892/or.2017.5743.
    PubMed     Abstract available

  140. LIU J, Li Y, Zou Y, Zhang J, et al
    MicroRNA-497 acts as a tumor suppressor in gastric cancer and is downregulated by DNA methylation.
    Oncol Rep. 2017 Jun 6. doi: 10.3892/or.2017.5698.
    PubMed     Abstract available

  141. BAI L, Guo CH, Zhao Y, Gao JG, et al
    SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients.
    Oncol Rep. 2017;37:3433-3440.
    PubMed     Abstract available

    May 2017
  142. ZHAO C, Li Y, Chen G, Wang F, et al
    Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3.
    Oncol Rep. 2017 May 26. doi: 10.3892/or.2017.5673.
    PubMed     Abstract available

  143. NING T, Zhang H, Wang X, Li S, et al
    miR-370 regulates cell proliferation and migration by targeting EGFR in gastric cancer.
    Oncol Rep. 2017 May 23. doi: 10.3892/or.2017.5660.
    PubMed     Abstract available

  144. NING T, Peng Z, Li S, Qu Y, et al
    miR-455 inhibits cell proliferation and migration via negative regulation of EGFR in human gastric cancer.
    Oncol Rep. 2017 May 22. doi: 10.3892/or.2017.5657.
    PubMed     Abstract available

  145. JIANG T, Dong P, Li L, Ma X, et al
    MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
    Oncol Rep. 2017 May 22. doi: 10.3892/or.2017.5659.
    PubMed     Abstract available

  146. LIU X, Duan C, Ji J, Zhang T, et al
    Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells.
    Oncol Rep. 2017 May 18. doi: 10.3892/or.2017.5648.
    PubMed     Abstract available

  147. LI LH, Wu GY, Lu YZ, Chen XH, et al
    p21-activated protein kinase 1 induces the invasion of gastric cancer cells through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase-2.
    Oncol Rep. 2017 May 16. doi: 10.3892/or.2017.5643.
    PubMed     Abstract available

  148. RAO M, Zhu Y, Cong X, Li Q, et al
    Knockdown of CREB1 inhibits tumor growth of human gastric cancer in vitro and in vivo.
    Oncol Rep. 2017 May 11. doi: 10.3892/or.2017.5636.
    PubMed     Abstract available

  149. LI W, Zhou Y, Yang J, Li H, et al
    Curcumin induces apoptotic cell death and protective autophagy in human gastric cancer cells.
    Oncol Rep. 2017 May 11. doi: 10.3892/or.2017.5637.
    PubMed     Abstract available

  150. LI X, Li J, Li F
    P21 activated kinase 4 binds translation elongation factor eEF1A1 to promote gastric cancer cell migration and invasion.
    Oncol Rep. 2017;37:2857-2864.
    PubMed     Abstract available

    April 2017
  151. JIN JJ, Dai FX, Long ZW, Cai H, et al
    CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
    Oncol Rep. 2017 Apr 25. doi: 10.3892/or.2017.5598.
    PubMed     Abstract available

  152. YAMAGUCHI T, Fushida S, Yamamoto Y, Tsukada T, et al
    Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer.
    Oncol Rep. 2017 Apr 19. doi: 10.3892/or.2017.5586.
    PubMed     Abstract available

    March 2017
  153. DUAN J, Chen L, Zhou M, Zhang J, et al
    MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression.
    Oncol Rep. 2017 Mar 22. doi: 10.3892/or.2017.5519.
    PubMed     Abstract available

  154. WANG Y, Xiao H, Wu H, Yao C, et al
    G protein subunit alpha q regulates gastric cancer growth via the p53/p21 and MEK/ERK pathways.
    Oncol Rep. 2017 Mar 13. doi: 10.3892/or.2017.5500.
    PubMed     Abstract available

  155. LIU Y, Sun Y, Zhao A
    MicroRNA-134 suppresses cell proliferation in gastric cancer cells via targeting of GOLPH3.
    Oncol Rep. 2017 Mar 2. doi: 10.3892/or.2017.5488.
    PubMed     Abstract available

  156. SUI W, Shi Z, Xue W, Ou M, et al
    Circular RNA and gene expression profiles in gastric cancer based on microarray chip technology.
    Oncol Rep. 2017;37:1804-1814.
    PubMed     Abstract available

  157. YU J, Wang X, Li Y, Tang B, et al
    Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1.
    Oncol Rep. 2017;37:1394-1400.
    PubMed     Abstract available

    February 2017
  158. TAMAKI R, Kanai-Mori A, Morishige Y, Koike A, et al
    Effects of 5-fluorouracil, adriamycin and irinotecan on HSC-39, a human scirrhous gastric cancer cell line.
    Oncol Rep. 2017 Feb 20. doi: 10.3892/or.2017.5470.
    PubMed     Abstract available

  159. WANG J, Zhou Y, Fei X, Chen X, et al
    ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.
    Oncol Rep. 2017 Feb 16. doi: 10.3892/or.2017.5460.
    PubMed     Abstract available

  160. SUN DP, Fang CL, Chen HK, Wen KS, et al
    EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5442.
    PubMed     Abstract available

  161. WANG L, Huang X, Chai Y, Zou L, et al
    Octreotide inhibits the proliferation of gastric cancer cells through P300-HAT activity and the interaction of ZAC and P300.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5451.
    PubMed     Abstract available

  162. HUANG Y, Li X, Sha H, Zhang L, et al
    Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5440.
    PubMed     Abstract available

    January 2017
  163. XIE R, Wang H, Jin H, Wen G, et al
    NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion.
    Oncol Rep. 2017 Jan 18. doi: 10.3892/or.2017.5386.
    PubMed     Abstract available

  164. CAO W, Wei W, Zhan Z, Xie D, et al
    Role of miR-647 in human gastric cancer suppression.
    Oncol Rep. 2017 Jan 17. doi: 10.3892/or.2017.5383.
    PubMed     Abstract available

  165. LI C, Lu S, Shi Y
    MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2.
    Oncol Rep. 2017 Jan 16. doi: 10.3892/or.2017.5370.
    PubMed     Abstract available

  166. LI A, Li J, Lin J, Zhuo W, et al
    COL11A1 is overexpressed in gastric cancer tissues and regulates proliferation, migration and invasion of HGC-27 gastric cancer cells in vitro.
    Oncol Rep. 2017;37:333-340.
    PubMed     Abstract available

    December 2016
  167. TANG C, Gong L, Zou W, Zhang J, et al
    Multivariate analysis of metastasisrelated risk factors for patients with gastroenteropancreatic neuroendocrine tumors based on clinicopathological and endoscopic features.
    Oncol Rep. 2016;36:3343-3352.
    PubMed     Abstract available

    November 2016
  168. LI W, Wang Z, Zha L, Kong D, et al
    HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer.
    Oncol Rep. 2016 Nov 18. doi: 10.3892/or.2016.5255.
    PubMed     Abstract available

  169. YANG C, Gao J, Yan N, Wu B, et al
    Propofol inhibits the growth and survival of gastric cancer cells in vitro through the upregulation of ING3.
    Oncol Rep. 2016 Nov 4. doi: 10.3892/or.2016.5218.
    PubMed     Abstract available

  170. LU X, Ma J, Qiu H, Yang L, et al
    Anti-proliferation effects of trifolirhizin on MKN45 cells and possible mechanism.
    Oncol Rep. 2016;36:2785-2792.
    PubMed     Abstract available

    October 2016
  171. ZHANG J, Zhu JS, Zhou Z, Chen WX, et al
    [Retracted] Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
    Oncol Rep. 2016 Oct 19. doi: 10.3892/or.2016.5181.
    PubMed     Abstract available

  172. CHEN B, Zhao J, Zhang S, Zhang Y, et al
    HPIP promotes gastric cancer cell proliferation through activation of cap-dependent translation.
    Oncol Rep. 2016 Oct 11. doi: 10.3892/or.2016.5157.
    PubMed     Abstract available

  173. FENG S, Zheng Z, Feng L, Yang L, et al
    Proton pump inhibitor pantoprazole inhibits the proliferation, selfrenewal and chemoresistance of gastric cancer stem cells via the EMT/betacatenin pathways.
    Oncol Rep. 2016 Oct 7. doi: 10.3892/or.2016.5154.
    PubMed     Abstract available

  174. CHEN SY, Zhang RG, Duan GC
    Pathogenic mechanisms of the oncoprotein CagA in H. pylori-induced gastric cancer (Review).
    Oncol Rep. 2016 Oct 4. doi: 10.3892/or.2016.5145.
    PubMed     Abstract available

    September 2016
  175. HUANG T, Zhou F, Wang-Johanning F, Nan K, et al
    Depression accelerates the development of gastric cancer through reactive oxygen speciesactivated ABL1 (Review).
    Oncol Rep. 2016 Sep 23. doi: 10.3892/or.2016.5127.
    PubMed     Abstract available

  176. XU H, Peng JG, Zhuang YF, Chen JJ, et al
    Establishment and characterization of an expanding-type gastric cancer cell line by Ming's classification.
    Oncol Rep. 2016 Sep 14. doi: 10.3892/or.2016.5090.
    PubMed     Abstract available

  177. LI J, Gao X, Ji K, Sanders AJ, et al
    Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.
    Oncol Rep. 2016 Sep 8. doi: 10.3892/or.2016.5074.
    PubMed     Abstract available

  178. BU X, Li M, Zhao Y, Liu S, et al
    Genetically engineered Newcastle disease virus expressing human interferon-lambda1 induces apoptosis in gastric adenocarcinoma cells and modulates the Th1/Th2 immune response.
    Oncol Rep. 2016;36:1393-402.
    PubMed     Abstract available

    June 2016
  179. OHNO T, Ohtani M, Suto H, Ohta M, et al
    Effect of green tea catechins on gastric mucosal dysplasia in insulin-gastrin mice.
    Oncol Rep. 2016;35:3241-7.
    PubMed     Abstract available

    April 2016
  180. PENG Y, Zhao Q, Zhang H, Han B, et al
    TIPE2, a negative regulator of TLR signaling, regulates p27 through IRF4-induced signaling.
    Oncol Rep. 2016;35:2480-6.
    PubMed     Abstract available

    March 2016
  181. WU Y, Zhang Q, Ruan Z, Yin Y, et al
    Intrinsic effects of gold nanoparticles on proliferation and invasion activity in SGC-7901 cells.
    Oncol Rep. 2016;35:1457-62.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.